Fingerprint
Dive into the research topics where Oliver Findling is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
-
Second-generation immunotherapeutics in multiple sclerosis: can we discard their precursors?
Findling, O. & Sellner, J., Feb 2021, In: Drug Discovery Today. 26, 2, p. 416-428 13 p.Research output: Journal article (peer-reviewed) › Review article
15 Link opens in a new tab Citations (Scopus) -
Cardiac Autonomic Dysfunction in Multiple Sclerosis: A Systematic Review of Current Knowledge and Impact of Immunotherapies
Findling, O., Hauer, L., Pezawas, T., Rommer, P. S., Struhal, W. & Sellner, J., Feb 2020, In: Journal of Clinical Medicine. 9, 2, 335.Research output: Journal article (peer-reviewed) › Review article
Open Access55 Link opens in a new tab Citations (Scopus) -
Dimethyl fumarate vs fingolimod following different pretreatments: A retrospective study
Diem, L., Daponte, A., Findling, O., Miclea, A., Briner, M., Salmen, A., Gold, R., Kilidireas, C., Chan, A., Evangelopoulos, M. E. & Hoepner, R., 01 Mar 2020, In: Neurology: Neuroimmunology and NeuroInflammation. 7, 2, e660.Research output: Journal article (peer-reviewed) › Journal article
Open Access5 Link opens in a new tab Citations (Scopus)